Matthias Zunhammer, PhD; Ulrike Bingel, MD; Tor D. Wager, PhD; et al.
JAMA Neurol. 2018;75(11):1321-1330. doi:10.1001/jamaneurol.2018.2017
This meta-analysis of participant-level data assesses the effect of placebo treatments on pain-associated functional neuroimaging responses in the neurologic pain signature, a multivariate brain pattern tracking nociceptive pain.
George Howard, DrPH; Lee H. Schwamm, MD; John P. Donnelly, PhD; et al.
JAMA Neurol. 2018;75(11):1331-1337. doi:10.1001/jamaneurol.2018.2101
This longitudinal cohort study compares quality of stroke care measures for patients admitted to hospitals participating and not participating in Get With The Guidelines–Stroke.
Rongcai Jiang, MD, PhD; Shiguang Zhao, MD, PhD; Renzhi Wang, MD, PhD; et al.
has active quiz
JAMA Neurol. 2018;75(11):1338-1346. doi:10.1001/jamaneurol.2018.2030
This randomized clinical trial evaluates the safety and efficacy of atrovastatin as a nonsurgical alternative for treating Chinese patients with chronic subdural hematoma.
Alexandra M. Wennberg, PhD; Nirubol Tosakulwong, BS; Timothy G. Lesnick, MS; et al.
has audio
JAMA Neurol. 2018;75(11):1347-1354. doi:10.1001/jamaneurol.2018.3139
This cross-sectional study investigates the association between apolipoprotein E ε4 and transative response DNA-binding protein 43 in US patients with an Alzheimer disease spectrum pathological diagnosis.
-
Audio Interview:
Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43
A. Sebastian López-Chiriboga, MD; Masoud Majed, MD; James Fryer, MS; et al.
has active quiz
JAMA Neurol. 2018;75(11):1355-1363. doi:10.1001/jamaneurol.2018.1814
This cohort study investigates whether serostatus of autoantibodies targeting myelin oligodendrocyte glycoprotein (transient vs persistent) and titer change over time provide clinical utility in predicting the likelihood of relapse in patients after acute disseminated encephalomyelitis.
Kristina Shkirkova, BS; Jeffrey L. Saver, MD; Sidney Starkman, MD; et al.
JAMA Neurol. 2018;75(11):1364-1374. doi:10.1001/jamaneurol.2018.1893
This exploratory analysis of 1690 patients enrolled in the Field Administration of Stroke Therapy-Magnesium Trial assesses the frequency, predictors, and outcomes of the neurological deterioration that occurs among patients during the ultra-early period after ischemic stroke or intracranial hemorrhage.
Emily L. Johnson, MD; Gregory L. Krauss, MD; Alexandra K. Lee, PhD, MSPH; et al.
JAMA Neurol. 2018;75(11):1375-1382. doi:10.1001/jamaneurol.2018.1935
This cohort study examines data from Atherosclerosis Risk in Communities Study to assess the association of midlife vascular and lifestyle risk factors with development of late-onset epilepsy.
Usha K. Misra, DM; Jayantee Kalita, DM; Mritunjai Kumar, DM
JAMA Neurol. 2018;75(11):1383-1391. doi:10.1001/jamaneurol.2018.2178
This randomized clinical trial evaluates the efficacy and safety of fludrocortisone in the treatment of cerebral salt wasting in patients with tuberculous meningitis.
Roos M. van der Vuurst de Vries, MD; Julia Y. Mescheriakova, MD; Yu Yi M. Wong, MD; et al.
JAMA Neurol. 2018;75(11):1392-1398. doi:10.1001/jamaneurol.2018.2160
This study evaluates the diagnostic accuracy of the 2017 McDonald criteria vs the 2010 criteria to predict clinically definite multiple sclerosis in patients with a typical clinically isolated syndrome.
Eleonore Bayen, MD, PhD; Katherine L. Possin, PhD; Yingjia Chen, PhD; et al.
JAMA Neurol. 2018;75(11):1399-1406. doi:10.1001/jamaneurol.2018.2210
This study investigates the prevalence of dementia and aging-related comorbidities, such as hypertension, epilepsy, anemia, and weight loss, in older adult individuals with Down syndrome.
Jordana Hughes, MD; Vilija Jokubaitis, PhD; Alessandra Lugaresi, PhD; et al.
JAMA Neurol. 2018;75(11):1407-1415. doi:10.1001/jamaneurol.2018.2109
This cohort study examines the association of superimposed relapses in progressive-onset multiple sclerosis on disease outcomes.